Loading companies…
Loading companies…
France · Biotech · Enterprise software
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | €33M | Bpifrance Investissement — Role not disclosedGordonMD Global Investments — Role not disclosedLamond Ventures — Role not disclosedMerck Ventures B.V. — Role not disclosedT. Andera Partners SAS — Role not disclosed |